Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7073]

Personalising prostate cancer screening may improve the accuracy of detection

Personalising prostate cancer screening may improve the accuracy of detection

New data informs treatment of blood cancer during pregnancy

New data informs treatment of blood cancer during pregnancy

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood cancer research

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood...

Initiative will test new drug combinations guided by tumour biology

Initiative will test new drug combinations guided by tumour biology

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

NCCN joins collaboration to improve standards in cancer care for vietnam

NCCN joins collaboration to improve standards in cancer care for vietnam

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging agent for prostate cancer

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging...

Certain cancers will likely rise exponentially due to COVID-19 screening delays

Certain cancers will likely rise exponentially due to COVID-19 screening delays

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

Major progress in curing brain tumours

Major progress in curing brain tumours

More from ecancer